However, soluble CD40L levels significantly declined to 9.00 ± 1.63 ng/mL after T2 compared with patients with thoracic aortic aneurysms (p < 0.01) (Fig. 3). The gene discussed is CD40LG; the disease is thoracic aortic aneurysm.